98139888 - IMMUNOLIGHT

Information

  • Trademark
  • 98139888
  • Serial Number
    98139888
  • Filing Date
    August 18, 2023
    a year ago
  • Transaction Date
    October 29, 2024
    2 months ago
  • Status Date
    October 29, 2024
    2 months ago
  • Published for Opposition Date
    September 03, 2024
    4 months ago
  • Location Date
    October 29, 2024
    2 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    VERHOSEK, WILLIAM
  • Attorney Docket Number
    18607-158010
    Attorney Name
    J. Derek Mason
    Law Office Assigned Location Code
    M50
  • Owners
Mark Drawing Code
4
Mark Identification
IMMUNOLIGHT
Case File Statements
  • GS0091: Energy storage systems comprised of solar cells, photovoltaic cells and modules and any combination thereof; optical fibers for light or color transmission; optical communication networks comprised of optical fibers
  • GS0051: Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disease and disorders; pharmaceutical agents for treating a disease, condition, or disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of tissues of a subject by detecting and triggering intracellular communication; preparations for sanitization and remediation of air supply, water supply, and biological materials for medical purposes
  • PM0001: IMMUNO LIGHT
  • GS0031: Additives for altering color in cosmetic preparations, namely, coloring preparations and non-medicated skin care preparations; cosmetic preparations
  • GS0021: Powdered energy converting additives for altering color in paint, pigment, and colorant preparations; paint preparations in the nature of paints and coatings containing particulate energy converting additives; pigment preparations in the nature of pigments containing particulate energy converting additives; colorant preparations in the nature of colorants containing particulate energy converting additives.
  • GS0011: Chemical additives for altering color in cosmetic preparations; substances in the nature of chemicals for use in solar cells and photovoltaic cells
  • GS0441: Medical services for treating a disease, condition, or disorder by detection of intercellular communication; medical services for treating a disease, condition, or disorder by detection of intracellular communication; medical services for treating a disease, condition, or disorder by detection and propagation of intercellular communication; medical services for treating a disease, condition, or disorder by detection and propagation of intracellular communication; medical services for treating a disease, condition, or disorder by triggering of intercellular communication; medical services for treating a disease, condition, or disorder by triggering of intracellular communication; medical services for biological tissue regeneration; medical services for the treatment of pain; medical services for the treatment of inflammation; medical services for the treatment of brain disorders; medical services for the treatment of cancer; medical services for the treatment of autoimmune disease or disorders
  • GS0101: Medical device for detection of biophotons; medical device for detection of intercellular communication; medical device for detection of intracellular communication; medical device for treating a disease, condition and disorder by detection of intercellular communication; medical device for treating a disease, condition and disorder by detection of intracellular communication; medical device for triggering of biophotons; medical device for detection of intercellular communication; medical device for triggering of intracellular communication; medical device for treating a disease, condition and disorder by triggering of intercellular communication; medical device for treating a disease, condition and disorder by triggering of intracellular communication
Case File Event Statements
  • 8/22/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/18/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/26/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/30/2024 - 11 months ago
    10 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 1/30/2024 - 11 months ago
    11 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 4/30/2024 - 8 months ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/30/2024 - 8 months ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/1/2024 - 8 months ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/30/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/30/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/30/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/31/2023 - a year ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/31/2023 - a year ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/31/2023 - a year ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/16/2024 - 7 months ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 5/16/2024 - 7 months ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/16/2024 - 7 months ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 7/24/2024 - 5 months ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/24/2024 - 5 months ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/24/2024 - 5 months ago
    18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 7/31/2024 - 5 months ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/14/2024 - 4 months ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/3/2024 - 4 months ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/3/2024 - 4 months ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/29/2024 - 2 months ago
    25 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM